
Matthew Rees
Contributor at The Wall Street Journal
Founder at Food and Health Facts
Matthew Rees, Founder, Food and Health Facts (former White House speechwriter), now highlighting America's toxic food culture and how it undermines human health
Articles
-
2 months ago |
investmentweek.co.uk | Matthew Rees
Strong views on the actual trajectory of US fiscal and trade policies are hostages to fortune and confidence is difficult to justify, but the market seems both happy that the new government's package will be supportive for growth and relatively unconcerned about the impacts of tariffs on domestic growth. The risk to the consensus view is to the downside, as the touted tariff package could be several times larger than that of Trump's last term of office.
-
Nov 12, 2024 |
nature.com | Alvaro Curiel-Garcia |Margo I Orlen |Clint A. Stalnecker |Julien Dilly |Marie C. Hasselluhn |Stephanie Chang | +16 more
Correction to: Nature https://doi.org/10.1038/s41586-024-07379-z Published online 8 April 2024In the version of the article initially published, in the Data availability section, the GEO accession number was incorrect and has now been amended to GSE252002 in the HTML and PDF version of the article.
-
Oct 15, 2024 |
onlinelibrary.wiley.com | Suheil Albert Atallah-Yunes |Matthew Rees |Raphael Mwangi |Robyn L. Kuchler
Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma (NHL) subtype in the world and most cases present with stages III/IV disease.1-3 These patients usually palpate a mass, develop pain, or have abnormal blood tests at the time of a routine exam leading to imaging, biopsy, and the diagnosis.
-
Jul 24, 2024 |
wsj.com | Matthew Rees
By P.H. Mullen (2001)1. Swimming typically attracts some of the highest television ratings of the Olympics, but most of the sport’s standouts train in nearly total anonymity.
-
Jul 22, 2024 |
nature.com | Matthew Rees |Radhika Bansal |Sikander Ailawadhi |Ricardo D. Parrondo |Saurabh Chhabra |Angela Dispenzieri | +9 more
AbstractThree classes of BCMA-directed therapy (BDT) exist: antibody drug-conjugates (ADCs), CAR-T, and T-cell engagers (TCEs), each with distinct strengths and weaknesses. To aid clinicians in selecting between BDTs, we reviewed myeloma patients treated at Mayo Clinic with commercial or investigational BDT between 2018-2023.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 412
- Tweets
- 666
- DMs Open
- No

https://t.co/E6gqZHIYTt

A lot of wisdom here from @TamarHaspel https://t.co/rqQQribv2C

RT @Super70sSports: If they need a fourth, I’m in … https://t.co/AOfoyOV0g3